rtmark
LearnBonds.com

Apple Inc. (AAPL) Quitely Building Health Data Empire, Acquires Gliimpse

Apple Inc (NASDAQ:AAPL) Apps

Apple Inc. has acquired Silicon Valley-based Gliimpse, a personal health data startup. The move, reported by Fast Company, was made earlier this year by the U.S. tech giant to boost its presence in digital health. Financial terms of the deal were not disclosed. Talking about the deal, the U.S. tech giant said that it buys smaller technology companies from time to time and generally doesn’t discuss its plans.

Manage Personal Health Data With Gliimpse

Gliimpse was founded by Anil Sethi and Karthik Hariharan in 2013. The startup offers a personal health data platform to collect, personalize, and share your health data. The company focuses on creating “personalized and shareable medical records” for every American across the country, according to its website.

Apple Inc (NASDAQ:AAPL) iPhone 7

Sethi, who started his career as a systems engineer at the iPhone maker in the late 1980s, is a serial entrepreneur, according to the report. Gliimpse is intended for patients with diseases like cancer and diabetes.

Recently, Apple appointed a top pediatric endocrinologist who developed a HealthKit app for teens with Type 1 diabetes.

Apple Betting on Healthcare

Apple wants to expand its presence in digital health. The acquisition is part of the company’s long-terms plans for the healthcare market. The company’s platforms – HealthKit, CareKit, and ResearchKit – allow patients, clinicians, and researchers to access important health and wellness data via a range of mobile devices.

According to the reports, Apple Inc.  is building a new health-tracking product to be launched next year. The company is reportedly finalizing suppliers for its new hardware, on which the company’s health-focused development team have been working for more than two years.

In addition, Apple has been expanding its healthcare team over the last few years. The company has tapped doctors, researchers and fitness experts to its team to build new capabilities in the Apple Watch as well as to develop platforms like HealthKit, ResearchKit and CareKit, according to a report by Apple Insider.

A report from Business Insider suggested that the company is quietly building one of the strongest teams in digital health. The company added Stephen Friend, co-founder and president of Sage Bionetworks, to its healthcare team in June. At that time, the company said it had “nothing more to share about his role or title.”

Earlier this year, CEO Tim Cook said Apple had “massive interest” in the health world and that the healthcare space is “ripe for simplicity and a new view.” Recently, Cook told Fast Company that he sees a major business opportunity in the non-regulated side of health care.

“We’ve gotten into the health arena and we started looking at wellness, that took us to pulling a string to thinking about research, pulling that string a little further took us to some patient-care stuff, and that pulled a string that’s taking us into some other stuff,” Cook said in an interview.

Shares of Apple Inc. have gained 12% during the past six months. Over the past five years, the company’s stock has more than doubled, and superseded the S&P 500, but it is still behind the tech giant Nasdaq Composite.

All trading carries risk. Views expressed are those of the writers only. Past performance is no guarantee of future results. The opinions expressed in this Site do not constitute investment advice and independent financial advice should be sought where appropriate. This website is free for you to use but we may receive commission from the companies we feature on this site.
Avatar
X

Leading Social Trading Platform with 0% Commission

Leading Social Trading Platform with 0% Commission

Leading Social Trading Platform with 0% Commission

TRADE WITH ETORO

75% of investors lose money when trading CFDs.

Leading Social Trading Platform with 0% Commission
TRADE WITH ETORO

75% of investors lose money when trading CFDs.

HTML Snippets Powered By : XYZScripts.com